297156
Effective Dual Method Contraceptive Use During First Sexual Intercourse and HPV Vaccination among U.S. Adolescent and Young Adult Females
METHODS: National Survey of Family Growth (2006-2010) data was used to examine the association between use of contraception during a woman’s first sexual intercourse and HPV vaccination. Women aged 15-24 years (n=2,691) served as the study sample.
FINDINGS: Overall, effective dual method contraception use during first sexual intercourse was reported by 10.1% of women; 28.6% reported receiving at least one dose of the HPV vaccine. Among women that used effective dual methods, 58.1% of girls ages 15-19 and 24.9% of women ages 20-24 reported receiving at least one dose of the HPV vaccine. Higher HPV vaccination rates among dual method users remained statistically significant for the adolescent age group in adjusted models.
CONCLUSIONS: Respectively, effective dual method contraception use during first sexual intercourse and HPV vaccination are low among adolescent and young adult females. However, this analysis supports the inverse tenet of Problem Behavior Theory wherein the protective behavior of dual method contraceptive use at first sexual intercourse may serve as a predictor of another complementary health behavior, HPV vaccination, particularly among adolescent females. Healthcare providers and parents may consider conversations about each of these individual behaviors as a teachable moment for the other health behavior.
Learning Areas:
Planning of health education strategies, interventions, and programsProtection of the public in relation to communicable diseases including prevention or control
Provision of health care to the public
Public health or related research
Social and behavioral sciences
Learning Objectives:
Describe the association between use of contraception during a woman’s first sexual intercourse and HPV vaccination.
Keyword(s): Immunizations, Contraception
Qualified on the content I am responsible for because: I have been the co-principal of multiple federally funded grants focusing on HPV vaccination research and cervical cancer prevention. Among my scientific interests has been the promotion of the uptake and adherence to the HPV vaccine among adolescent and young adult women, specifically in rural America.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.